Subjective evaluation of the clinical efficacy of a nasal spray.

Ipclin - Pesquisa Clínica Integrada0 个研究点开始时间: 2019年6月10日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Age: 18 to 65 years
•Female and male. Full skin in the study region (nose). Phototypes I to IV. Participants who agree to adhere to the procedures and requirements of the study and to attend the Institution on the days and times determined for the evaluations. Participants who have the capacity to consent to their participation, signing the Informed Consent Term (TCLE). Participants who agree not to use products of the same category during the conduct of this research. Participants who have not participated in similar studies for at least 2 months prior to the study.

•Diseases or medications that may directly interfere with the study or endanger the health of the research participant, according to the physician responsible for including study participants.
•Immunodeficiencies. Renal, cardiac or hepatic transplanted. Erythema solar in the study region due to intense sun exposure 1 month before the study. Current use of the following medicines: corticoids, antihistamines, immunosuppressants, retinoids, anti-inflammatories. Participants who refuse to participate in the study in question.
•Any condition that could interfere with the evaluations according to the investigator of the study.

发起方

Ipclin - Pesquisa Clínica Integrada